Fresenius Medical Care Plans to Exit China Peritoneal Dialysis Business

MT Newswires Live09-26 00:05

Fresenius Medical Care (FMS) said Friday it has refined its China commercial strategy, with plans to discontinue production and sales of 4008A hemodialysis system locally and exit its China peritoneal dialysis business while maintaining its existing obligations.

The company said it expects portfolio optimization actions to result in one-time costs of approximately 110 million euros ($125.3 million) to be recognized in Q3.

As part of these actions, Fresenius Medical Care said it bolstered local leadership, with the appointment of market General Manager Rex Liu and improving focus on innovative technologies for in-center dialysis and critical care.

Price: 22.69, Change: +0.34, Percent Change: +1.52

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2670868426?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-26 00:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2670868426","market":"sh","top_or_hot":-1,"title":"Fresenius Medical Care Plans to Exit China Peritoneal Dialysis Business","media":"MT Newswires Live","content":"<html><body><p> Fresenius Medical Care (FMS) said Friday it has refined its China commercial strategy, with plans to discontinue production and sales of 4008A hemodialysis system locally and exit its China peritoneal dialysis business while maintaining its existing obligations.</p><p>The company said it expects portfolio optimization actions to result in one-time costs of approximately 110 million euros ($125.3 million) to be recognized in Q3.</p><p>As part of these actions, Fresenius Medical Care said it bolstered local leadership, with the appointment of market General Manager Rex Liu and improving focus on innovative technologies for in-center dialysis and critical care.</p><p>Price: 22.69, Change: +0.34, Percent Change: +1.52</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Fresenius Medical Care Plans to Exit China Peritoneal Dialysis Business</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFresenius Medical Care Plans to Exit China Peritoneal Dialysis Business\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-09-26 00:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Fresenius Medical Care (FMS) said Friday it has refined its China commercial strategy, with plans to discontinue production and sales of 4008A hemodialysis system locally and exit its China peritoneal dialysis business while maintaining its existing obligations.</p><p>The company said it expects portfolio optimization actions to result in one-time costs of approximately 110 million euros ($125.3 million) to be recognized in Q3.</p><p>As part of these actions, Fresenius Medical Care said it bolstered local leadership, with the appointment of market General Manager Rex Liu and improving focus on innovative technologies for in-center dialysis and critical care.</p><p>Price: 22.69, Change: +0.34, Percent Change: +1.52</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4196","symbol_name":"保健护理服务","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2670868426","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2670868426","pubTimestamp":1790352302,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Fresenius Medical Care  said Friday it has refined its China commercial strategy, with plans to discontinue production and sales of 4008A hemodialysis system locally and exit its China peritoneal dialysis business while maintaining its existing obligations.The company said it expects portfolio optimization actions to result in one-time costs of approximately 110 million euros  to be recognized in Q3.As part of these actions, Fresenius Medical Care said it bolstered local leadership, with the appointment of market General Manager Rex Liu and improving focus on innovative technologies for in-center dialysis and critical care.Price: 22.69, Change: +0.34, Percent Change: +1.52","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4196":"保健护理服务","FMS":"费森尤斯医疗","FMS.AU":"Flinders Mines","BK7129":"钢铁"},"translate_title":"费森尤斯医疗计划退出中国腹膜透析业务","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"FMS":1,"FMS.AU":1},"content_text":"Fresenius Medical Care (FMS) said Friday it has refined its China commercial strategy, with plans to discontinue production and sales of 4008A hemodialysis system locally and exit its China peritoneal dialysis business while maintaining its existing obligations.The company said it expects portfolio optimization actions to result in one-time costs of approximately 110 million euros ($125.3 million) to be recognized in Q3.As part of these actions, Fresenius Medical Care said it bolstered local leadership, with the appointment of market General Manager Rex Liu and improving focus on innovative technologies for in-center dialysis and critical care.Price: 22.69, Change: +0.34, Percent Change: +1.52","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2670868426","isCrawlerRequest":true}